Paradoxical effect of imipramine in hyperprolactinemic female rats exposed to the forced swimming test

Physiology and Behavior

Volumn 68, Issue 5, 2000, Pages 619-623

  Ribeiro, M F ^a   Ferigolo, M ^b   Reis, F M ^a   Barros, H M T ^b   Spritzer, P M ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Estrogen; Female; Hyperprolactinemia; Imipramine

Indexed keywords

ESTRADIOL BENZOATE; ESTROGEN; IMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORCED SWIMMING TEST; HYPERPROLACTINEMIA; IMMOBILIZATION; LOCOMOTION; MOOD; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

EID: 0034108751     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(99)00199-7     Document Type: Article

References (32)

1. Stowe Z.N., Nemeroff C.B. Women at risk for postpartum-onset major depression. Am J Obstet Gynecol. 173:1995;639-645.
2. Pearistein T.B. Hormones and depression. what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol. 173:1995;646-653.
3. Etgen A.M., Karkanias G.B. Estrogen regulation of noradenergic signaling in the hypothalamus. Psychoneuroendocrinology. 19:1994;603-610.
4. Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 48(5):1997;16S-20S.
5. Sichel D.A., Cohen L.S., Robertson L.M., Ruttenberg A., Rosenbaum J.F. Profhylactic estrogen in recurrent postpartum affective disorder. Biol Psychiatry. 38:1995;814-818.
6. 3H]dopamine release from dispersed rat tubero-infundibular dopaminergic neurons and dopamine decreases gonadotropin-releasing hormone release induced by calcium ionophore. Acta Endocrinol. 129:1993;548-553.
7. Voogt J.L., De Greef W.J., Visser T.J., Koning J., Vreeburg J.T.M., Weber R.F.A. In vivo release of dopamine, luteinizing hormone-releasing hormone and thyrotropin-releasing hormone in male rats bearing a prolactin-secreting tumor. Neuroendocrinology. 46:1987;110-116.
8. Koppelman M.C.S., Parry B.L., Hamilton J.A., Alagna S.W., Loriaux D.L. Effect of bromocriptine on affect and libido in hyperprolactinemia. Am J Psychiatry. 144:1987;1037-1041.
9. Mattox J.H., Buckman M.T., Bernstein J., Pathak D., Kellner R. Dopamine agonists for reducing depression associated with hyperprolactinemia. J Reprod Med. 31:1986;694-698.
10. Bridges R.S., Robertson M.C., Shiu R.P.C., Sturgis J.D., Henriquez B.M., Mann P.E. Central lactogenic regulation of maternal behavior in rats. steroid dependence, hormone specificity, and behavioral potencies of rat prolactin and rat placental lactogen I Endocrinology. 138:1997;756-763.
11. Drago F., Bohus B., Gispen W.H., Scapagnini U., De Wied D. Prolactin-enhanced grooming behavior. interaction with ACTH Brain Res. 163:1983;277-282.
12. Drago F., Bohus B., Mattheij A.M. Endogenous hyperprolactinemia and avoidance behaviors of the rat. Physiol Behav. 28(1):1982;1-4.
13. Harlan R.E., Shivers B.D., Pfaff D.W. Midbrain microinfusions of prolactin increase the estrogen-dependent behavior, lordosis. Science. 219:1983;1451-1453.
14. Noel M.B., Woodside B. Effects of systemic and central prolactin injections on food intake, weight gain, and estrous cyclicity in female rats. Physiol Behav. 54:1993;151-154.
15. Sobrinho L.G. The psychogenic effects of prolactin. Acta Endocrinol. 129(1):1993;38-40.
16. Drago F., Scapagnini U. Effects of endogenous hyperprolactinemia on opiate-induced behavior changes in rats. Brain Res. 336:1985;215-221.
17. King T.S., Steger R.W., Morgfan W.W. Effect of hypophysectomy and subsequent prolactin administration of hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats. Endocrinology. 116:1985;485-491.
18. Perkins N.A., Westfall T.C., Paul C.V., MacLeod R., Rogol A.D. Effect of prolactin on dopamine synthesis in medial basal hypothalamus. evidence for a short loop feedback Brain Res. 160:1979;431-444.
19. Sarkar D.K. Evidence for prolactin feedback action on hypothalamic oxytocin, vasoactive intestinal peptide and dopamine secretion. Neuroendocrinology. 49:1989;520-524.
20. Ribeiro M.F., Spritzer P.M., Barbosa-Coutinho L.M., Oliveira M.C., Pavanato M.A., Silva I.S.B., Reis R.M. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats. a fruitful experimental model of estrogen-dependent hyperprolatinemia Braz J Med Biol Res. 30:1997;113-117.
21. Spritzer P.M., Ribeiro M.F., Oliveira M.C., Barbosa-Coutinho L.M., Silva I.S.B., Dahlem N., Cericatto R., Pavanato M.A. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats. Horm Metab Res. 28:1996;171-176.
22. Adler R.A. The anterior pituitary-grafted rat. a valid model of chronic hyper-prolactinemia Endocr Rev. 7:1986;302-313.
23. Reis F.M., Santos M.A.R., Reis A.M., Coimbra C.C. Effects of hyperprolactinemia on plasma glucose and prolactin in rats exposed to ether stress. Physiol Behav. 56:1994;495-499.
24. Barros H.M.T., Ferigolo M. Ethopharmacology of imipramine in the forced-swimming test. gender differences Neurosci Biobehav Rev. 23:1998;279-286.
25. Lappöhn R.E., Van de Wiel H.B.M., Brownell J. The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia. Fertil Steril. 58:1992;321-327.
26. Drago F., Pulvirenti L., Spadaro F., Pennisi G. Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats. Psycho-neuroendocrinology. 15:1990;349-356.
27. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioral despair in rats. a new model to antidepressant treatments Eur J Pharmacol. 47:1978;379-391.
28. Bhavsar V.H., Dhumal V.R., Kelkar V.V. The effect of estradiol on the alterations in monoamine-mediated behavioural responses induced by administration of eletroconvulsive shocks or imipramine to female rats. Neropharmacology. 22:1983;751-756.
29. King T.S., Carrillo A.J., Morgan W.W. Hyperprolactinemia attenuates ovarian steroid stimulation of region-specific hypothalamic serotonin synthesis and luteinizing hormone release in ovariectomized rats. Neuroendocrinology. 43:1986;597-602.
30. Coccaro E.F., Silverman J.M., Klar H.M., Horvath T.B., Siever L.J. Familial correlates of reduced central serotonergic system function in patients with personality disorders. Arch Gen Psychiatry. 51(4):1994;318-324.
31. Harms P.G., Langlier P., McCann S.M. Modification of stress-induced prolactin release by dexamethasone or adrenalectomy. Endocrinology. 96:1975;475-478.
32. Magiakou M.A., Mastorakos G., Rabin D., Dubbert B., Chrousos G.P. Hypothalamic corticotropin-releasing hormone suppression during post-partum period. implications for the increase of psychiatric manifestations in this period J Clin Endocrinol Metabol. 81:1996;1912-1917.